The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 123K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldsmith, K.
Right arrow Articles by Hendricks, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldsmith, K.
Right arrow Articles by Hendricks, R. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/2/341/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 3, February 2, 1998 341-348


Articles

Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response

Kim Goldsmith*, Wei Chen{ddagger}, David C. Johnson*, and Robert L. Hendricks{ddagger}

From the * Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, Oregon 97201, and the {ddagger} Department of Ophthalmology and Visual Sciences, and the Department of Pathology, University of Illinois at Chicago, Chicago, Illinois 60612

The herpes simplex virus (HSV) infected cell protein (ICP)47 blocks CD8+ T cell recognition of infected cells by inhibiting the transporter associated with antigen presentation (TAP). In vivo, HSV-1 replicates in two distinct tissues: in epithelial mucosa or epidermis, where the virus enters sensory neurons; and in the peripheral and central nervous system, where acute and subsequently latent infections occur. Here, we show that an HSV-1 ICP47 mutant is less neurovirulent than wild-type HSV-1 in mice, but replicates normally in epithelial tissues. The reduced neurovirulence of the ICP47 mutant was due to a protective CD8+ T cell response. When compared with wild-type virus, the ICP47 mutant expressed reduced neurovirulence in immunologically normal mice, and T cell–deficient nude mice after reconstitution with CD8+ T cells. However, the ICP47 mutant exhibited normal neurovirulence in mice that were acutely depleted of CD8+ T cells, and in nude mice that were not reconstituted, or were reconstituted with CD4+ T cells. In contrast, CD8+ T cell depletion did not increase the neurovirulence of an unrelated, attenuated HSV-1 glycoprotein (g)E mutant. ICP47 is the first viral protein shown to influence neurovirulence by inhibiting CD8+ T cell protection.


Address correspondence to Robert L. Hendricks at his current address, Department of Ophthalmology, Rm. 920, Eye and Ear Institute, University of Pittsburgh Medical Center, 203 Lothrop St., Pittsburgh, PA 15213. Phone: 412-647-5754; Fax: 412-647-5880; E-mail: bobhend{at}vision.eei.upmc.edu

1 Abbreviations used in this paper: gE, glycoprotein E; HSV, herpes simplex virus; ICP, infected cell protein; TAP, the transporter associated with antigen presentation.

K. Goldsmith and Wei Chen contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS